Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma
Rituximab is a chimeric anti-CD20 monoclonal antibody that is a widely used for the treatment of B cells non-Hodgkin lymphoma. The use of chemotherapy regimens containing rituximab in HCV-positive patients with non-Hodgkin lymphoma has been associated with liver dysfunction, but no cases of cholesta...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2015-09-01
|
| Serie: | Annals of Hepatology |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S1665268119307732 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|